HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
14.62
-1.12 (-7.12%)
Apr 25, 2025, 4:00 PM EDT - Market closed
HUTCHMED (China) Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for HUTCHMED (China) stock has a target of 19, which predicts an increase of 29.96% from the current stock price of 14.62.
Analyst Consensus: Hold
* Price targets were last updated on Aug 1, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for HUTCHMED (China) is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | +29.96% | Aug 1, 2024 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $20 → $22 | Hold → Strong Buy | Upgrades | $20 → $22 | +51.16% | Nov 24, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | +16.28% | Nov 10, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +242.00% | Sep 5, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +242.00% | Jul 24, 2023 |
Financial Forecast
Revenue This Year
812.81M
from 630.20M
Increased by 28.98%
Revenue Next Year
978.72M
from 812.81M
Increased by 20.41%
EPS This Year
0.47
from 0.04
Increased by 1,063.77%
EPS Next Year
0.13
from 0.47
Decreased by -71.46%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.0B | 1.3B | 1.7B | ||
| Avg | 812.8M | 978.7M | 1.3B | ||
| Low | 680.1M | 715.4M | 1.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 59.6% | 58.8% | 74.2% | ||
| Avg | 29.0% | 20.4% | 34.5% | ||
| Low | 7.9% | -12.0% | 16.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.71 | 0.23 | 0.39 |
| Avg | 0.47 | 0.13 | 0.21 |
| Low | 0.28 | -0.08 | 0.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1,677.2% | -50.2% | 195.6% |
| Avg | 1,063.8% | -71.5% | 57.1% |
| Low | 598.3% | - | -19.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.